STL Volume 24 Number 2

4 POSTS 0 COMMENTS
Purchase PDF for $2.79
Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis

Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis

Glycopyrronium tosylate (Qbrexza), a topical anticholinergic therapy, has been shown to be effective in the treatment of primary axillary hyperhidrosis.
Crisaborole Eucrisa for AtopicDermatitis

Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis

Crisaborole represents a novel and efficacious therapeutic approach for the treatment of mild to moderate Atopic Dermatitis and demonstrates early and continued decrease in pruritus, which improves quality of life and reduces the potential risk of infection and scarring.
Skin Treatments Introduced in 2018

Skin Treatments Introduced in 2018

A list of skin treatments introduced in 2018, categorized by type/class of therapy. The content primarily focuses on approvals issued by US and Canadian drug regulatory agencies and is sourced from both regulatory and industry news releases.
Update on Drugs and Drug News

Update on Drugs & Devices: March – April 2019

Latest drug update covers Pembrolizumab, Oral JAK + SYK dual inhibitor, Lidocaine 7% + tetracaine 7% local anesthetic cream and PrabotulinumtoxinA-xvfs.

POPULAR